2012
DOI: 10.4103/1119-3077.104533
|View full text |Cite
|
Sign up to set email alerts
|

Reconstruction of the chest wall after excision of a giant malignant peripheral nerve sheath tumor

Abstract: Primary chest wall tumors are uncommon and constitute 0.2-2% of all tumors. Metastatic tumors and tumors of local extension are more common. Malignant peripheral nerve sheath tumor (MPNST) of the chest wall is even rarer and its incidence on the chest wall not stated in the literature. The incidence in the general population is 0.0001% while the risk is approximately 4600 times higher in patients with type I neurofibromatosis and 3-13% of them will finally develop into MPNST, usually after latent periods of 10… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Patients usually get symptomatic with palpable mass or pain and both symptoms at the site of tumor. 2 7 8 Defects of the chest wall occur due to tumor ablation, radiation injury, infection, and trauma. 9 Chest wall may be reconstructed with musculocutaneous flaps, such as latissimus dorsi (LD) musculocutaneous flap or free flaps combined with the synthetic or autologous materials used to prevent pneumothorax and paradoxical chest wall motion.…”
Section: Discussionmentioning
confidence: 99%
“…Patients usually get symptomatic with palpable mass or pain and both symptoms at the site of tumor. 2 7 8 Defects of the chest wall occur due to tumor ablation, radiation injury, infection, and trauma. 9 Chest wall may be reconstructed with musculocutaneous flaps, such as latissimus dorsi (LD) musculocutaneous flap or free flaps combined with the synthetic or autologous materials used to prevent pneumothorax and paradoxical chest wall motion.…”
Section: Discussionmentioning
confidence: 99%
“…The risk of an MPNST is approximately 4,600 times higher in patients with type 1 neurofibromatosis (NF-1), with 3% to 13% of people with NF-1 developing a MPNST. 1 Clinically, a MPNST is known to be aggressive, locally invasive, and highly metastatic. The mainstay of treatment for a MPNST is a wide margin surgical excision.…”
mentioning
confidence: 99%